Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
Chen GF, Wei L, Chen J, Duan ZP, Dou XG, Xie Q, Zhang WH, Lu LG, Fan JG, Cheng J, Wang GQ, Ren H, Wang JP, Yang XX, Jia ZS, Fu QC, Wang XJ, Shang J, Zhang YX, Han Y, Du N, Shao Q, Ji D, Li F, Li B, Liu JL, Niu XX, Wang C, Wu V, Wong A, Wang YD, Hou JL, Jia JD, Zhuang H, Lau G.
Chen GF, et al. Among authors: wang yd, wang xj, wang jp, wang c, wang gq.
PLoS One. 2016 Jun 8;11(6):e0155934. doi: 10.1371/journal.pone.0155934. eCollection 2016.
PLoS One. 2016.
PMID: 27276081
Free PMC article.